STUDIES ON THE INTERACTION BETWEEN PRESYNAPTIC ALPHA-2-ADRENOCEPTORS AND ADENOSINE-A1-RECEPTORS LOCATED ON NORADRENERGIC NERVE-TERMINALS

被引:28
作者
ALLGAIER, C
GREBER, R
HERTTING, G
机构
[1] Institute of Pharmacology and Toxicology, University of Freiburg, Freiburg i. Br., W-7800
关键词
NORADRENALINE RELEASE; PRESYNAPTIC ALPHA-2-ADRENOCEPTORS; PRESYNAPTIC ADENOSINE-A1 RECEPTORS; ENDOGENOUS NORADRENALINE; ENDOGENOUS ADENOSINE; RABBIT HIPPOCAMPUS;
D O I
10.1007/BF00167217
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of the present study was to obtain a more detailed understanding of the interaction between presynaptic alpha-2-adrenoceptors and A1 adenosine receptors mediating inhibition of noradrenaline release in the central nervous system. Slices of rabbit hippocampus, prelabelled with [H-3]noradrenaline, were superfused in the presence of the re-uptake inhibitor (+)-oxaprotiline and electrically stimulated during superfusion. During stimulation with 36 pulses at 3 Hz the alpha-2-adrenoceptor antagonist yohimbine induced a five-fold increase of noradrenaline release indicating a pronounced autoinhibition of approximately 80%. In these experiments the inhibition of release caused by R-PIA, a preferential A1 agonist, as well as its facilitation caused by DPCPX, a selective A1 antagonist, were smaller in comparison to the effects of these compounds on release virtually free of autoinhibition (i.e. by stimulating the tissue with 4 pulses at 100 Hz (POP-stimulation) or with 36 pulses at 3 Hz in presence of yohimbine). Clonidine, an alpha-2-adrenoceptor agonist, was used to impose a distinct alpha-2-adrenoceptor-mediated inhibition of release elicited by POP-stimulation. Only, however, in the presence of 30 nmol/l clonidine, causing maximum inhibition of approximately 80% of H-3-overflow, but not in the presence of 6 nmol/l clonidine, causing approximately 50% inhibition, a significant diminution of the inhibitory effect of R-PIA was seen. Similarly, the alpha-2-adrenoceptor mechanism was affected only by 10-mu-mol/l R-PIA causing maximum inhibition of approximately 80%, but remained unchanged in the presence of 30 nmol/l R-PIA diminishing release by 50%. In addition, the alpha-2-adrenoceptor-mediated inhibition remained unaffected in the presence of DPCPX, indicating that the concentration of endogenous adenosine attained was not sufficient to influence the alpha-2-adrenoceptor mechanism. In conclusion, the present results suggest that activation of the presynaptic alpha-2 and A1 receptors inhibits depolarization-induced noradrenaline release in an additive manner. Only extensive (near maximal or maximal) activation of one receptor mechanism impairs the inhibition due to activation of the other.
引用
收藏
页码:187 / 192
页数:6
相关论文
共 23 条
[1]   PRESYNAPTIC KAPPA-OPIOID RECEPTORS ON NORADRENERGIC NERVE-TERMINALS COUPLE TO G-PROTEINS AND INTERACT WITH THE ALPHA2-ADRENOCEPTORS [J].
ALLGAIER, C ;
DASCHMANN, B ;
SIEVERLING, J ;
HERTTING, G .
JOURNAL OF NEUROCHEMISTRY, 1989, 53 (05) :1629-1635
[2]   ENDOGENOUS NORADRENALINE IMPAIRS THE PROSTAGLANDIN-INDUCED INHIBITION OF NORADRENALINE RELEASE [J].
ALLGAIER, C ;
JAGER, T ;
HERTTING, G .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1989, 340 (04) :472-474
[3]   THE ADENOSINE RECEPTOR-MEDIATED INHIBITION OF NORADRENALINE RELEASE POSSIBLY INVOLVES A N-PROTEIN AND IS INCREASED BY ALPHA-2-AUTORECEPTOR BLOCKADE [J].
ALLGAIER, C ;
HERTTING, G ;
KUGELGEN, OV .
BRITISH JOURNAL OF PHARMACOLOGY, 1987, 90 (02) :403-412
[4]  
ALLGAIER C, 1991, IN PRESS J PHARM EXP
[5]  
ALLGAIER C, 1991, IN PRESS ADV BIOSCIE
[6]   POSSIBLE FEEDBACK INHIBITION OF NORADRENALINE RELEASE BY PURINE COMPOUNDS [J].
ENERO, MA ;
SAIDMAN, BQ .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1977, 297 (01) :39-46
[7]   ACTIVATION OF A1 ADENOSINE RECEPTORS DECREASES THE RELEASE OF SEROTONIN IN THE RABBIT HIPPOCAMPUS, BUT NOT IN THE CAUDATE-NUCLEUS [J].
FEUERSTEIN, TJ ;
BAR, KI ;
LUCKING, CH .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1988, 338 (06) :664-670
[8]   IDENTIFICATION OF MECHANISMS INVOLVED IN THE MODULATION OF RELEASE OF NORADRENALINE IN THE HIPPOCAMPUS OF THE RABBIT INVITRO [J].
JACKISCH, R ;
WERLE, E ;
HERTTING, G .
NEUROPHARMACOLOGY, 1984, 23 (12A) :1363-1371
[9]   ADENOSINE - AN ENDOGENOUS MODULATOR OF HIPPOCAMPAL NORADRENALINE RELEASE [J].
JACKISCH, R ;
FEHR, R ;
HERTTING, G .
NEUROPHARMACOLOGY, 1985, 24 (06) :499-507
[10]  
LIMBERGER N, 1988, N-S ARCH PHARMACOL, V338, P53